Loading data
ACTGNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 285.23 m USD | 122.31 m USD | 125.1 m USD | 59.22 m USD | 88.05 m USD |
| Cost of revenue | 200.75 m USD | 92.66 m USD | 52.83 m USD | 37.39 m USD | 36.1 m USD |
| Gross profit | 84.48 m USD | 29.65 m USD | 72.27 m USD | 21.84 m USD | 51.95 m USD |
| Research and development expense | — | — | 735 k USD | 626 k USD | 200 k USD |
| Operating profit | 6.41 m USD | -32.93 m USD | 20.94 m USD | -40.09 m USD | 14.55 m USD |
| Profit before tax | 31.31 m USD | -38.15 m USD | 67.43 m USD | -127.15 m USD | 174.65 m USD |
| Income tax expense | 6.84 m USD | -3.45 m USD | -1.5 m USD | -16.21 m USD | 24.29 m USD |
| Net income (reported basis) | 24.47 m USD | -34.7 m USD | 68.93 m USD | -110.94 m USD | 150.37 m USD |
| Net income attributable to common shareholders | 21.68 m USD | -36.06 m USD | 55.14 m USD | -133.04 m USD | 118.8 m USD |
| Basic earnings per share | 0.23 USD/share | -0.36 USD/share | 0.73 USD/share | -3.13 USD/share | 2.43 USD/share |
| Diluted earnings per share | 0.22 USD/share | -0.36 USD/share | 0.58 USD/share | -3.13 USD/share | 1.91 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.